Compare JSPR & MGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JSPR | MGN |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 33.6M |
| IPO Year | N/A | N/A |
| Metric | JSPR | MGN |
|---|---|---|
| Price | $1.41 | $2.89 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $18.13 | N/A |
| AVG Volume (30 Days) | ★ 388.6K | 361.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.33 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $1.00 |
| 52 Week High | $7.19 | $3.99 |
| Indicator | JSPR | MGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 69.17 |
| Support Level | $1.40 | $1.42 |
| Resistance Level | $1.44 | N/A |
| Average True Range (ATR) | 0.10 | 0.43 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 85.32 | 90.44 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.